OnKure Therapeutics (OKUR) awards 22,350 stock options to director Phillips
Rhea-AI Filing Summary
OnKure Therapeutics, Inc. director Andrew John Phillips received a grant of stock options covering 22,350 shares of Class A common stock at an exercise price of $4.14 per share. The options expire on August 6, 2036 and vest 100% on the earlier of June 4, 2027 or the day prior to the company’s next annual meeting of stockholders, contingent on his continued service. Following this award, he holds options on 22,350 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Phillips Andrew John
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 22,350 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 22,350 shares (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option will vest on the earlier of June 4, 2027 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.
Key Figures
Option shares granted: 22,350 shares
Exercise price: $4.14 per share
Expiration date: August 6, 2036
+2 more
5 metrics
Option shares granted
22,350 shares
Stock Option (right to buy) award to director Andrew John Phillips
Exercise price
$4.14 per share
Conversion or exercise price of the stock option
Expiration date
August 6, 2036
Expiration of the stock option award
Total options after grant
22,350 shares
Total derivative securities beneficially owned following the transaction
Vesting date reference
June 4, 2027
100% vesting on earlier of this date or day prior to next annual meeting
Key Terms
Stock Option (right to buy), exercise price, vest, annual meeting of stockholders, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 4.1400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"100% of the shares subject to the option will vest on the earlier"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"the date of the Issuer's next annual meeting of stockholders"
service provider financial
"subject to the Reporting Person continuing as a service provider"
FAQ
What equity award did Andrew John Phillips receive from OKUR?
Andrew John Phillips received a stock option grant for 22,350 shares of OnKure Therapeutics Class A common stock, with an exercise price of $4.14 per share and expiration on August 6, 2036, reported as directly held.
When do Andrew John Phillips’ new OKUR stock options vest?
The options vest 100% on the earlier of June 4, 2027 or the day prior to OnKure Therapeutics’ next annual meeting of stockholders, conditioned on Phillips continuing as a service provider through the applicable vesting date.
What is the exercise price of Andrew John Phillips’ OKUR stock options?
The reported exercise price is $4.14 per share for the stock options covering 22,350 underlying shares of OnKure Therapeutics Class A common stock, as disclosed in the derivative transaction details.
Is the reported OKUR transaction a market purchase or sale?
The filing reports a grant/award acquisition of stock options, coded as an "A" transaction, rather than an open-market purchase or sale. It is a compensation-related derivative award with no per-share purchase price paid at grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
